/ /

Lisette Hilton
Lisette Hilton is president of Words Come Alive, based in Boca Raton, Florida.
Researchers claim global skincare market is growing
A report published by U.S. based market research company Grand View Research suggests the global skincare products market will reach $196.67 billion by 2024, up from an estimated $129.21 billion in 2015.
8 things about formulating products
Skincare product formulating is a natural for dermatologists, but there are several important considerations before starting what can be an expensive, time-consuming process.
Crowdsourcing pinpoints unmet needs in eczema research
A new study using crowdsourcing harnesses the power of social media chatter to better understand unmet needs in eczema research.
Clinical nuances of psoriasis in darker skin
There are important differences in and misconceptions about the prevalence, clinical presentation and treatment of skin of color versus Caucasian psoriasis patients. Dermatologist Andrew F. Alexis, M.D., M.P.H., share his insight about what dermatologists need to know when treating psoriasis skin of color patients.
Common pediatric disorders in skin of color
Although pediatric atopic dermatitis and acne have some similarities among children with skin of color and lighter-skinned children, there are important differences when these common skin conditions affect darker skin types.
Study links hard water to eczema
Domestic water hardness and chlorine have been suggested as important risk factors for atopic dermatitis (AD). One recent study by researchers from Kings College London, United Kingdom, explored the potential associations between domestic water calcium carbonate (CaCO3) and chlorine concentrations in home water systems, damage to the skin's natural barrier, and incidences of AD in infancy.
Survey puts spotlight on a big problem for children with eczema: Bullying
Many children with eczema suffer from bullying because of the skin condition. A new survey reflects what children and caregivers are experiencing, beyond the itch.
FDA approves etanercept biosimilar for psoriasis, psoriatic arthritis
The FDA approved the biosimilars Erelzi for plaque psoriasis and Enbrel for psoriatic arthritis.
Study highlights what helps, doesn’t help ADHD kids with homework
New research examines the effects of behavioral, psychostimulant, and combined treatments on homework issues among children with attention-deficit/hyperactivity disorder (ADHD).
Genomic profile products enhanced to better predict immunotherapy response
Foundation Medicine, based in Cambridge, Mass., announced in late August the addition of new clinical markers to its genomic profile products FoundationOne and FoundationOne Heme.